US-supported international HIV research, particularly that conducted in African countries, has direct benefits to Americans.

California-based drugmaker takes advantage of surging share price to strike takeovers after a quiet couple of years ...

Past Phoenix Center employees say over a decade of grant fraud has led to the state freezing funds for the center.

National Institutes of Health Director Dr. Jay Bhattacharya attempted to reassure members of Congress on both sides of the ...

Dr. Paula Cannon, a Distinguished Professor at USC, is researching gene therapy approaches to engineer immune cells that ...

Acquisition Adds Clinical Stage Bispecific BCMAxCD3 T Cell Engager with Potential for Durable Immune Reset to Gilead’s Inflammation Portfolio ---- Gilead Intends to Enter into a Strategic ...

South Africa’s National Aids Council, Sanac, has asked local drug companies to submit applications by April 7 to make generic versions of an anti-HIV jab that could end Aids by 2043 in the country.

Congress must ensure that the transition of PEPFAR to full partner country ownership is data-driven, includes input from ...

Zoliflodacin and gepotidacin make oral therapy viable again for urogenital gonorrhea, yet lower pharyngeal efficacy and weak resistance surveillance mean clinicians must adopt cautious, targeted use.

US aid cuts have left Kenya exposed to rising disease outbreaks, climate shocks, and looming pandemic threats.

South Africa’s National Aids Council has launched a renewed effort to secure licences to make generic versions of lenacapavir ...

The National Aids Commission (NAC) has been operating without a board for five months, raising concerns about oversight and ...